RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma

P. Therasse; A. Le Cesne; M. Van Glabbeke; J. Verweij; I. Judson

doi:10.1016/j.ejca.2005.04.005

RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma

European Journal of Cancer ◽

10.1016/j.ejca.2005.04.005 ◽

2005 ◽

Vol 41 (10) ◽

pp. 1426-1430 ◽

Cited By ~ 54

Author(s):

P. Therasse ◽

A. Le Cesne ◽

M. Van Glabbeke ◽

J. Verweij ◽

I. Judson

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Response Criteria ◽

Advanced Soft Tissue Sarcoma ◽

Prospective Comparison

Download Full-text

Efficacy and safety of apatinib in advanced soft tissue sarcoma: A multi-center, open-label phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.11546 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 11546-11546

Author(s):

Wenxi Yu ◽

Zhengfu Fan ◽

Jing Chen ◽

Hong-Mei Zhang ◽

Xing Zhang ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Efficacy And Safety ◽

Open Label ◽

Advanced Soft Tissue Sarcoma ◽

Open Label Phase

Download Full-text

Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial

Melanoma Research ◽

10.1097/cmr.0b013e32832985e3 ◽

2009 ◽

Vol 19 (2) ◽

pp. 106-111 ◽

Cited By ~ 19

Author(s):

Mary S. Brady ◽

Karen Brown ◽

Ami Patel ◽

Charles Fisher ◽

Will Marx

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Final Report

Download Full-text

Abstract CT111: Preclinical justification for the Phase II clinical trial ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma

10.1158/1538-7445.am2019-ct111 ◽

2019 ◽

Author(s):

Bethany C. Prudner ◽

Richa Rathore ◽

Abigail Godec ◽

Samuel F. Chang ◽

Angela Hirbe ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

Abstract CT111: Preclinical justification for the Phase II clinical trial ADI-PEG 20 in combination with gemcitabine and docetaxel for the treatment of soft tissue sarcoma

10.1158/1538-7445.sabcs18-ct111 ◽

2019 ◽

Author(s):

Bethany C. Prudner ◽

Richa Rathore ◽

Abigail Godec ◽

Samuel F. Chang ◽

Angela Hirbe ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Clinical Trial

Download Full-text

A phase II clinical trial of echinomycin in metastatic soft tissue sarcoma

Investigational New Drugs ◽

10.1007/bf00872868 ◽

1995 ◽

Vol 13 (2) ◽

pp. 171-174 ◽

Cited By ~ 23

Author(s):

William J. Gradishar ◽

Nicholas J. Vogelzang ◽

Lary J. Kilton ◽

Steven J. Leibach ◽

Alfred W. Rademaker ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Metastatic Soft Tissue Sarcoma

Download Full-text

Faculty Opinions recommendation of Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718556209.793500073 ◽

2014 ◽

Author(s):

Richard Riedel

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Antitumor Activity ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Soft Tissue Sarcoma

Download Full-text

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: Results of a phase II – Study of the EORTC Soft Tissue and Bone Sarcoma Group

European Journal of Cancer ◽

10.1016/j.ejca.2007.01.014 ◽

2007 ◽

Vol 43 (6) ◽

pp. 1017-1022 ◽

Cited By ~ 18

Author(s):

P. Reichardt ◽

O.S. Nielsen ◽

S. Bauer ◽

J.T. Hartmann ◽

P. Schöffski ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Bone Sarcoma ◽

Adult Patients ◽

Advanced Soft Tissue Sarcoma

Download Full-text

Oral piritrexim ? A phase II study in patients with advanced soft tissue sarcoma

Investigational New Drugs ◽

10.1007/bf00873124 ◽

1992 ◽

Vol 10 (2) ◽

pp. 97-98 ◽

Cited By ~ 9

Author(s):

Judith D. Schiesel ◽

Matthew Carabasi ◽

Gordon Magill ◽

Ephraim Casper ◽

Edgar Cheng ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Soft Tissue Sarcoma

Download Full-text

140 A two-stage phase II study of the matrix metalloproteinase inhibitor (MMPI) Col-3 in patients with advanced soft tissue sarcoma (ASTS) — report of stage I data

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80148-4 ◽

2004 ◽

Vol 2 (8) ◽

pp. 45

Author(s):

K. Papadopoulos ◽

Q. Chu ◽

S. Syed ◽

J. Curtright ◽

G. Schwartz ◽

...

Keyword(s):

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Matrix Metalloproteinase ◽

Phase Ii ◽

Phase Ii Study ◽

Stage I ◽

Matrix Metalloproteinase Inhibitor ◽

Two Stage ◽

Advanced Soft Tissue Sarcoma ◽

The Matrix

Download Full-text

Randomized, Open, Prospective, Phase II Clinical Trial of Doxorubicin (DOXO) vs. Trabectedin Plus Doxo in the First-Line Treatment of Patients (PTS) with Advanced Non-Operable and/or Metastatic Soft Tissue Sarcomas (STS): Geis-20 Study

Annals of Oncology ◽

10.1016/s0923-7534(20)34065-5 ◽

2012 ◽

Vol 23 ◽

pp. ix490 ◽

Cited By ~ 1

Author(s):

J. Martin Broto ◽

X. Garcia Del Muro ◽

A. Lopez-Pousa ◽

R. Las De Penas ◽

J. Maurel ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Phase Ii ◽

Soft Tissue Sarcomas ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

Prospective Phase ◽

First Line Treatment

Download Full-text